The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer - Wikidata - awgldk - TriplyDB

The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer

The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer

http://www.wikidata.org/entity/Q35065968

about

Hallmarks of glycosylation in cancer Emerging blood-based biomarkers for detection of gastric cancer Solvent interaction analysis as a proteomic approach to structure-based biomarker discovery and clinical diagnostics.Serum Glycans as Risk Markers for Non-Small Cell Lung Cancer.Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer.Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans.Glycans and glycoproteins as specific biomarkers for cancer.A genome-wide analysis of gene-caffeine consumption interaction on basal cell carcinoma.Discovery of Non-invasive Glycan Biomarkers for Detection and Surveillance of Gastric Cancer The Use of Multiple Reaction Monitoring on QQQ-MS for the Analysis of Protein- and Site-Specific Glycosylation Patterns in Serum.Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.Sample handling of gastric tissue and O-glycan alterations in paired gastric cancer and non-tumorigenic tissues.

P2860

Q26752363-9B85204C-BB2B-42BE-BBDD-B3E6ADD83911 Q26778026-A1495FFC-E4E1-4BA7-B370-4DA83F6A3339 Q30381260-4A9D74FA-4752-4D1F-9817-108749A4D54F Q36759054-1D38E429-8C8A-49BC-804D-BFA67FD0A97B Q36860418-356C7D80-B283-494F-8304-E7A68843D4FF Q37461186-69B5244B-7232-4419-A75B-621F497A7C12 Q38945184-5F7FCEA7-541E-413E-A74A-B4E5BEC5991D Q40503483-3B3A15B1-19B5-4B7F-BF54-34BBB474B2C2 Q41396310-04CF0806-39F6-49B8-BB82-4BC8BF37EE5F Q43677119-65346E7A-E38F-4638-B99F-D10AB0B995F7 Q47585189-65FBF861-B5FC-4D07-88E7-627CE29D41EC Q49865262-FE67F276-9F83-49E8-89CC-192715666EE2

P2860

The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer

http://www.wikidata.org/entity/Q35065968

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer

@ast

The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer

@en

type

label

The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer

@ast

The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer

@en

prefLabel

The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer

@ast

The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer

@en

P1433

Q35065968-2325AA50-76D3-49AC-A634-1FC859935BD2

P1476

Q35065968-F4FD3303-720D-44F0-94A1-FB7AA5166075

P2093

Q35065968-228C176E-842B-40FB-A612-9CB3402ABEE7

Q35065968-3E267CCF-3729-42F8-A730-5C3748142EED

Q35065968-408D3A74-1E2D-4450-B736-10E265855A90

Q35065968-498A576E-F1B8-4FD3-86F8-BA1779765325

Q35065968-4E6A23CE-8BD8-4446-9185-9343FF81A3C6

Q35065968-5FAB7605-16DC-4A88-A938-DFBFDF854D45

Q35065968-93BB66DC-2F6A-4CF3-8E36-F0795447A223

Q35065968-BF5A1A35-1AD2-4FD3-89AD-291442B857B7

Q35065968-CFB28EDD-A0AD-4631-973B-D31F7466B8D6

Q35065968-F84BE25D-67D7-4449-B3C1-15026401EF73

P2860

Q35065968-0F17A312-A5ED-4176-A600-06DEC1008076

Q35065968-162C8408-A32B-4D45-9FA2-A2BBE3B37484

Q35065968-1A54BDD3-6A67-4C1E-A5B0-B2748DFDFF49

Q35065968-1DBA92B9-486E-4F06-94B7-1E51E3F24E52

Q35065968-1E5E1A28-EB92-45C8-8521-8ABBA7FE1C92

Q35065968-2B074B50-50E0-49A2-870E-A404C0BABEF9

Q35065968-2C1990DB-7736-4A39-BEE6-5F9F76111375

Q35065968-33E2A4D2-E230-4416-AFC0-BA6ABC7EE819

Q35065968-3AA5696A-CFDE-4459-88BF-D7FC170167B2

Q35065968-3AE77A71-C5CC-491A-A8F7-4434EB1BEF53

P304

Q35065968-41072788-B2DA-4E94-945F-727B4961ACFD

P31

Q35065968-DA3D2D9C-B73D-4D6A-9331-6394E9574A5A

P356

Q35065968-4F98FF3D-5C11-4924-B68B-E56B4C3DD3F7

P478

Q35065968-6944713C-2B66-45A9-B7FD-7A6DE1D84317

P50

Q35065968-85B768D0-14E8-435E-B2EA-AE8C6D2D501B

Q35065968-F2E804A4-C77E-4052-B339-8F4C87DFBEBC

P577

Q35065968-31E8C564-804F-4F9D-A1F4-646DE4313E0E

P5875

Q35065968-312E890C-D84D-4FA4-9D3B-DB6293D1C084

P698

Q35065968-BFF96911-AA79-4E22-87AC-E954C1FD9932

P921

Q35065968-B7D0F003-BA29-4417-B1F1-FDA73AAA46E2

P932

Q35065968-CFB6D364-6036-4701-A3A7-6D42324A8E88

P356

J.EUPROT.2014.11.002

P1433

EuPA open proteomics

P1476

The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer

@en

P2093

Cara L Cooke

http://www.w3.org/2001/XMLSchema#string

Carlito B Lebrilla

http://www.w3.org/2001/XMLSchema#string

Carol Stroble

http://www.w3.org/2001/XMLSchema#string

Cynthia C Williams

http://www.w3.org/2001/XMLSchema#string

David M Rocke

http://www.w3.org/2001/XMLSchema#string

Donald A Barkauskas

http://www.w3.org/2001/XMLSchema#string

Javier Torres

http://www.w3.org/2001/XMLSchema#string

Lauren D Wu

http://www.w3.org/2001/XMLSchema#string

Margarita Camorlinga

http://www.w3.org/2001/XMLSchema#string

Sureyya Ozcan

http://www.w3.org/2001/XMLSchema#string

P2860

Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Developments in the identification of glycan biomarkers for the detection of cancer

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

Helicobacter pylori infection and the risk of gastric carcinoma

THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

A serum glycomics approach to breast cancer biomarkers.

The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome.

Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study

IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EUPROT.2014.11.002

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269724690

http://www.w3.org/2001/XMLSchema#string

P698

25685702

http://www.w3.org/2001/XMLSchema#string

P921

P932

4322429

http://www.w3.org/2001/XMLSchema#string